Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
ophthalmic solution
|
| gptkbp:activeDuring |
gptkb:bromfenac
|
| gptkbp:administrativeDivision |
twice daily
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Xibrom
|
| gptkbp:clinicalTrials |
Phase III
ophthalmology NCT00123456 NCT00123457 |
| gptkbp:contraindication |
visual disturbances
active ocular infection conjunctival hyperemia corneal deposits hypersensitivity_to_bromfenac |
| gptkbp:dosageForm |
solution
|
| gptkbp:drugInterdiction |
anti-inflammatory agents
prescription only ophthalmic agents |
| gptkbp:formulation |
sterile solution
|
| gptkbp:healthcare |
keep out of reach of children
shake well before use store upright discard after 28 days of opening do not touch dropper tip to any surface |
| https://www.w3.org/2000/01/rdf-schema#label |
Xibrom
|
| gptkbp:issuedBy |
eye drops
|
| gptkbp:lastProduced |
2005
|
| gptkbp:mandates |
post-operative inflammation
|
| gptkbp:manufacturer |
gptkb:Bausch_+_Lomb
|
| gptkbp:marketedAs |
gptkb:Canada
gptkb:United_States Europe |
| gptkbp:notableFeature |
gptkb:Nepafenac
gptkb:Ketorolac Diclofenac |
| gptkbp:packaging |
bottle
|
| gptkbp:passenger_traffic |
5 mL
|
| gptkbp:patentStatus |
patented
|
| gptkbp:safetyFeatures |
monitor for allergic reactions
not recommended during breastfeeding not recommended during pregnancy use with caution in elderly patients |
| gptkbp:sideEffect |
headache
eye irritation dry eye burning sensation in the eye |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
non-steroidal anti-inflammatory drug (NSAID)
|
| gptkbp:usedFor |
treatment of inflammation
|